NasdaqGM - Delayed Quote USD
Structure Therapeutics Inc. (GPCR)
22.72
+0.89
+(4.08%)
At close: June 11 at 4:00:01 PM EDT
22.22
-0.50
(-2.20%)
After hours: June 11 at 7:49:41 PM EDT
Insider Purchases Last 6 Months
| Shares | Transactions | |
|---|---|---|
| Purchases | 0 | 0 |
| Sales | -- | 0 |
| Net Shares Purchased (Sold) | 0 | 0 |
| Total Insider Shares Held | 4.72M | -- |
| % Net Shares Purchased (Sold) | -- | -- |
Net Institutional Purchases Prior Quarter to Latest Quarter
| Shares | |
|---|---|
| Net Shares Purchased (Sold) | -- |
| % Change in Institutional Shares Held | -- |
Insider Transactions Reported - Last Two Years
| Insider | Transaction | Type | Value | Date |
|---|---|---|---|---|
| STEVENS RAYMOND C Chief Executive Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 14, 2025 |
| HALL ASHLEY Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 14, 2025 |
| LIN XICHEN Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 14, 2025 |
| YOON JUN Chief Financial Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 14, 2025 |
| COLL CRESPO BLAS Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 14, 2025 |
| HALL ASHLEY Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Sep 18, 2024 |
| COLL CRESPO BLAS Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Sep 18, 2024 |
| LIN XICHEN Officer | Conversion of Exercise of derivative security at price 52.74 per share. | Direct | 5,600,988 | Jun 3, 2024 |
| LIN XICHEN Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 15, 2024 |
| BACH MARK ALLEN Officer | Stock Award(Grant) at price 0.00 per share. | Direct | 0 | Mar 15, 2024 |
Related Tickers
TERN Terns Pharmaceuticals, Inc.
4.1000
+0.99%
MGX Metagenomi, Inc.
1.4900
-5.10%
MDGL Madrigal Pharmaceuticals, Inc.
294.34
+4.26%
MTSR Metsera, Inc.
33.06
-5.81%
CYTK Cytokinetics, Incorporated
33.11
-4.14%
VKTX Viking Therapeutics, Inc.
28.95
-0.65%
ALT Altimmune, Inc.
6.54
-2.97%
KYTX Kyverna Therapeutics, Inc.
3.3100
-8.06%
AKRO Akero Therapeutics, Inc.
52.96
-2.87%
SRRK Scholar Rock Holding Corporation
33.01
-4.10%